IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 46 filers reported holding IMMUNOCORE HLDGS PLC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $152,778,549 | -15.9% | 2,943,710 | -2.8% | 4.09% | -5.3% |
| Q2 2023 | $181,583,464 | +22.4% | 3,028,410 | +0.9% | 4.32% | +22.0% |
| Q1 2023 | $148,402,169 | -21.7% | 3,001,662 | -9.6% | 3.54% | -22.4% |
| Q4 2022 | $189,533,237 | +15.6% | 3,321,066 | -4.9% | 4.56% | +7.7% |
| Q3 2022 | $163,996,000 | +64.5% | 3,493,743 | +30.8% | 4.24% | +46.0% |
| Q2 2022 | $99,679,000 | +30.6% | 2,671,652 | +4.7% | 2.90% | +51.0% |
| Q1 2022 | $76,306,000 | -9.8% | 2,552,034 | +3.3% | 1.92% | -1.7% |
| Q4 2021 | $84,626,000 | -6.6% | 2,471,555 | +1.1% | 1.96% | +2.6% |
| Q3 2021 | $90,642,000 | -3.1% | 2,445,155 | +2.1% | 1.91% | +3.1% |
| Q2 2021 | $93,517,000 | -4.2% | 2,394,785 | +4.5% | 1.85% | -13.2% |
| Q1 2021 | $97,583,000 | – | 2,292,285 | – | 2.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $28,523,073 | 25.19% |
| Velan Capital Investment Management LP | 200,000 | $9,888,000 | 8.43% |
| RTW INVESTMENTS, LP | 5,649,943 | $279,333,182 | 5.82% |
| Paradigm Biocapital Advisors LP | 1,126,256 | $55,682,097 | 5.28% |
| Rock Springs Capital Management LP | 3,001,662 | $148,402,169 | 3.54% |
| Logos Global Management LP | 500,000 | $24,720,000 | 3.54% |
| TANG CAPITAL MANAGEMENT LLC | 405,600 | $20,052,864 | 2.99% |
| GREAT POINT PARTNERS LLC | 255,367 | $12,625,344 | 2.48% |
| COWEN AND COMPANY, LLC | 405,174 | $20,031,802 | 2.35% |
| Eschler Asset Management LLP | 60,000 | $2,966,400 | 2.34% |